StockClub

IDXG

IDXGInterpace Biosciences, Inc.$ --
Interpace Biosciences, Inc.

Interpace Biosciences, Inc.

IDXG

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
9M USD
YoY -25.1%
Operating Income
2M USD
YoY -48.6%
Net Income
23M USD
YoY +683.4%
EPS
5.13$
YoY +677.3%

Revenue

$38.7M
FY2024 Q1$10.3M
$10.3M
Q1
FY2024 Q2$22.3M
$22.3M
Q2
FY2024 Q3$34.6M
$34.6M
Q3
FY2024 Q4$46.9M
$46.9M
Q4
FY2025 Q1$11.5M
$11.5M
Q1
FY2025 Q2$20.7M
$20.7M
Q2
FY2025 Q3$29.5M
$29.5M
Q3
FY2025 Q4$38.7M
$38.7M
Q4
Actual
$-8.2M (-17.5%)

Net Income

$24.6M
FY2024 Q1$468,000
$468,000
Q1
FY2024 Q2$2.5M
$2.5M
Q2
FY2024 Q3$3.8M
$3.8M
Q3
FY2024 Q4$6.7M
$6.7M
Q4
FY2025 Q1$1.6M
$1.6M
Q1
FY2025 Q2$1M
$1M
Q2
FY2025 Q3$1.9M
$1.9M
Q3
FY2025 Q4$24.6M
$24.6M
Q4
Actual
+$17.9M (+266.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$32.4M
Est:$32.3M
FY2020BEAT
$32.4M
FY2021MISS
Actual:$41.3M
Est:$42M
FY2021MISS
$41.3M
FY2022MISS
Actual:$31.8M
Est:$46.9M
FY2022MISS
$31.8M
FY2023MISS
Actual:$40.2M
Est:$54.5M
FY2023MISS
$40.2M
FY2024MISS
Actual:$46.9M
Est:$121.7M
FY2024MISS
$46.9M
FY2025MISS
Actual:$38.7M
Est:$52.5M
FY2025MISS
$38.7M

Analyst Estimates

No forecast data